Pediatric cardiologist Kirk Milhoan, MD, PhD, has been named chair of the CDC's Advisory Committee on Immunization Practices (ACIP). Milhoan reportedly blamed vaccines for causing cardiovascular ...
It’s a common practice — maintaining peripheral intravenous catheters (PIVCs) in stable hospital patients even after the need for IV therapy has been resolved. And the thinking goes, why not? After ...
TCT 603: Performance of Aortic Valve Coefficient (AVC) in Relation with Calcium Score (CS) and Aortic Valve Area (AVA) in Patients Undergoing TAVR Receive the the latest news, research, and ...
Palantir said on Thursday it had struck a partnership with Lumen Technologies that will see the telecommunications company using the data management company’s AI software to build capabilities to ...
BILLERICA, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. (AVI), a leader in advanced vascular access solutions, today announced that the U.S. Food and Drug Administration (FDA) cleared a new ...
Access Vascular, Inc. (AVI), a leader in advanced vascular access solutions, today announced that the U.S. Food and Drug Administration (FDA) cleared a new indication for its single-lumen MIMIX® ...
Lumen Technologies, Inc. LUMN is making major strides in building the backbone for the artificial intelligence (AI)-driven economy, with plans to deploy 34 million new intercity fiber miles by 2028.
Progress in 2025 includes millions of new fiber miles, significant added network capacity, and coast-to-coast build momentum Infographic: Lumen accelerates multi-billion-dollar network expansion to ...
Starting in October, Microsoft will enforce multi-factor authentication (MFA) for all Azure resource management actions to protect Azure clients from unauthorized access attempts. This change is part ...
MINNEAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced it has received U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results